Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Appili Therapeutics Inc (APLIF)

Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Appili Therapeutics Inc 21-1344 SUMMER ST. HALIFAX A5 B3H 0A8 CAN

www.appilitherapeutics.com P: 902-442-4655

Description:

Appili Therapeutics Inc. is a biopharmaceutical company. It acquires, develops and commercializes novel medicines for unmet needs in the infectious disease. The company's lead product consist ATI-2307, ATI-1501 and ATI-1701 which are in clinical stage. Appili Therapeutics Inc. is based in Halifax, Canada.

Key Statistics

Overview:

Market Capitalization, $K 3,371
Enterprise Value, $K 7,301
Shares Outstanding, K 121,266
Annual Sales, $ 280 K
Annual Net Income, $ -6,990 K
Last Quarter Sales, $ 360 K
Last Quarter Net Income, $ -110 K
EBIT, $ -5,820 K
EBITDA, $ -5,810 K
60-Month Beta -0.30
% of Insider Shareholders 11.84%
% of Institutional Shareholders 0.00%
Float, K 106,908
% Float 88.16%
Short Volume Ratio 0.57

Growth:

1-Year Return 2.96%
3-Year Return -96.67%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 02/13/24
Latest Earnings Date N/A
Earnings Per Share ttm -0.04
EPS Growth vs. Prev Qtr 100.00%
EPS Growth vs. Prev Year 100.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

APLIF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -229.96%
Profit Margin % -2,496.43%
Debt/Equity -0.82
Price/Sales 3.83
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.06
Interest Coverage -7.39
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar